The regulatory submission process in life sciences is becoming less about assembling documents and more about proving trust. For years, submission readiness was largely treated as an end-stage operational milestone: finalize the analysis, validate the outputs and package everything for regulators. But that model is beginning to break down under
Clinical trials are the most costly, time-consuming, and heavily regulated stages in drug development, often costing hundreds of millions of dollars and sometimes exceeding a billion dollars. Every month of delay cuts into the patent-protected window that determines a drug’s commercial viability, with companies losing tens of millions of dollars
Inequities in cancer care cause specific populations in the U.S. and worldwide to bear a more significant burden of disease than the general population, based upon barriers. These barriers to prevention and care have long existed but were undeniably exacerbated by the COVID-19 pandemic. February 4 marks World Cancer Day, which
